Huijing Ye

1.3k total citations
54 papers, 469 citations indexed

About

Huijing Ye is a scholar working on Pathology and Forensic Medicine, Ophthalmology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Huijing Ye has authored 54 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pathology and Forensic Medicine, 21 papers in Ophthalmology and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Huijing Ye's work include Ophthalmology and Eye Disorders (22 papers), Glaucoma and retinal disorders (10 papers) and Ocular Oncology and Treatments (8 papers). Huijing Ye is often cited by papers focused on Ophthalmology and Eye Disorders (22 papers), Glaucoma and retinal disorders (10 papers) and Ocular Oncology and Treatments (8 papers). Huijing Ye collaborates with scholars based in China, South Korea and Philippines. Huijing Ye's co-authors include Huasheng Yang, Rongxin Chen, Wei Xiao, Yuxiang Mao, Te Zhang, Y. X. Ding, Huasheng Yang, Ping Zhang, Zhichang Liu and Qian Li and has published in prestigious journals such as JAMA, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Huijing Ye

47 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huijing Ye China 13 200 170 120 106 97 54 469
Piotr Miśkiewicz Poland 13 261 1.3× 100 0.6× 82 0.7× 94 0.9× 330 3.4× 41 584
Luis J. Mejico United States 14 97 0.5× 190 1.1× 324 2.7× 88 0.8× 44 0.5× 29 613
Giulia Lanzolla Italy 18 440 2.2× 134 0.8× 115 1.0× 81 0.8× 369 3.8× 41 726
Weiqing Wang China 10 192 1.0× 54 0.3× 63 0.5× 81 0.8× 265 2.7× 25 454
M. B. Davies United Kingdom 9 231 1.2× 60 0.4× 138 1.1× 104 1.0× 18 0.2× 12 476
Iris M.M.J. Wakelkamp Netherlands 11 685 3.4× 219 1.3× 188 1.6× 48 0.5× 513 5.3× 14 864
Lara Frommer Germany 14 200 1.0× 40 0.2× 38 0.3× 63 0.6× 403 4.2× 25 693
Ildikó Molnár Hungary 12 168 0.8× 55 0.3× 17 0.1× 103 1.0× 186 1.9× 38 433
Nilusha Manji United Kingdom 4 141 0.7× 31 0.2× 41 0.3× 52 0.5× 508 5.2× 6 721
Chuandi Zhou China 16 36 0.2× 420 2.5× 80 0.7× 292 2.8× 21 0.2× 50 827

Countries citing papers authored by Huijing Ye

Since Specialization
Citations

This map shows the geographic impact of Huijing Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huijing Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huijing Ye more than expected).

Fields of papers citing papers by Huijing Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huijing Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huijing Ye. The network helps show where Huijing Ye may publish in the future.

Co-authorship network of co-authors of Huijing Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Huijing Ye. A scholar is included among the top collaborators of Huijing Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huijing Ye. Huijing Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Han, Xu Wang, Frank Wu, et al.. (2025). Emodin-induced ERα degradation via SYVN1 alleviates vascular calcification by preventing HIF-1α deacetylation in chronic kidney disease. Phytomedicine. 145. 156915–156915. 3 indexed citations
2.
Hu, Zhi, Huijing Ye, Ma J, et al.. (2025). Overexpression of OsCAX2 in indica rice reduces cadmium accumulation in grains without yield loss. Journal of Integrative Agriculture. 25(1). 390–393. 1 indexed citations
3.
Hu, Zhi, Huijing Ye, Xintong Liu, et al.. (2024). Overexpression of a high affinity nitrate transporter NtNRT2.1 significantly improves the nicotine content in Nicotiana tabacum. Industrial Crops and Products. 224. 120326–120326. 1 indexed citations
5.
Ye, Huijing, et al.. (2024). GSDMD mediated pyroptosis induced inflammation of Graves’ orbitopathy via the NF-κB/ AIM2/ Caspase-1 pathway. Experimental Eye Research. 240. 109812–109812. 5 indexed citations
6.
Ye, Huijing, et al.. (2023). FTY‐720 alleviates diabetes‐induced liver injury by inhibiting oxidative stress and inflammation. Fundamental and Clinical Pharmacology. 37(5). 960–970. 5 indexed citations
7.
8.
Ye, Huijing, et al.. (2023). Study on the effect of cartoon video education before orbital operation. Minerva Gastroenterology. 70(1). 112–114.
9.
Wang, Xing, Huijing Ye, Rongxin Chen, et al.. (2023). HbA1c: an independent risk factor for dysthyroid optic neuropathy. Frontiers in Endocrinology. 14. 1251209–1251209. 1 indexed citations
10.
Shi, Lu, Huijing Ye, Jun Huang, et al.. (2021). IL-38 Exerts Anti-Inflammatory and Antifibrotic Effects in Thyroid-Associated Ophthalmopathy. The Journal of Clinical Endocrinology & Metabolism. 106(8). e3125–e3142. 22 indexed citations
11.
Ye, Huijing, Wei Xiao, Yuxiang Mao, et al.. (2021). Increased Dysfunctional and Plastic Regulatory T Cells in Idiopathic Orbital Inflammation. Frontiers in Immunology. 12. 634847–634847. 12 indexed citations
12.
Wang, Xing, Huijing Ye, Lu Shi, et al.. (2021). Disulfiram Exerts Antiadipogenic, Anti-Inflammatory, and Antifibrotic Therapeutic Effects in an In Vitro Model of Graves' Orbitopathy. Thyroid. 32(3). 294–305. 11 indexed citations
13.
Xiao, Wei, et al.. (2021). Tear cytokine profiles in patients with extranodal marginal zone B-cell lymphoma of the ocular adnexa. Eye. 36(7). 1396–1402. 3 indexed citations
14.
Zhang, Ping, Huijing Ye, Wei Xiao, et al.. (2020). Clinical features and outcomes of IgG4-related idiopathic orbital inflammatory disease: from a large southern China-based cohort. Eye. 35(4). 1248–1255. 11 indexed citations
16.
Du, Yi, Huijing Ye, Rongxin Chen, Wenjing Luo, & Huasheng Yang. (2018). Clinical differences between predominantly fat increase and muscle increase subtypes of thyroid eye disease in Chinese patients.. 50(1). 87–91. 1 indexed citations
17.
Li, Qian, Huijing Ye, Y. X. Ding, et al.. (2017). Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases. PLoS ONE. 12(5). e0176064–e0176064. 44 indexed citations
18.
Du, Yi, Huijing Ye, Kaijun Li, et al.. (2013). Vision-Related Quality of Life Tends to be More Severely Impaired in Patients with Dysthyroid Optic Neuropathy. Current Eye Research. 39(5). 532–536. 11 indexed citations
19.
Ye, Huijing, et al.. (2012). Clinical features of 8 cases of orbital sparganosis in southern China. Canadian Journal of Ophthalmology. 47(5). 453–457. 1 indexed citations
20.
Ye, Huijing, et al.. (2011). PRIMARY CONJUNCTIVAL RHABDOMYOSARCOMA SUCCESSFULLY TREATED WITH SURGERY AND CHEMOTHERAPY. 23(4). 65–68. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026